Real Estate / REIT - Healthcare FacilitiesUpdated 2026-05-10 22:07 UTC

XRN stock hub

Chiron Real Estate Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

XRNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

464.9M

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

XRN

In the news

Latest news · XRN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.5P50 28.2P75 47.4

Trailing P/En/a

P25 15P50 26.1P75 39.7

ROE-1.7

P25 -2.3P50 4.2P75 9.3

ROIC1.9

P25 0.6P50 2.5P75 4.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All XRN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

212

Groups with data

Currency

USD

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001688882
Company name	Chiron Real Estate Inc.
Country	United States
Country code	US
Cusip	37954A303
Employees	30
Employees Change	4%
Employees Change Percent	15.38
Enterprise value	$1.1B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	REIT - Healthcare Facilities
Isin	US37954A3032
Last refreshed	2026-05-10
Market cap	$464.9M
Market cap category	Small-Cap
Price	$33.99
Price currency	USD
Rev Per Employee	5,051,100x
Sector	Real Estate
Symbol	XRN
Website	https://www.globalmedicalreit.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.22%
EV Sales Forward	7.3x
EV/EBIT	30.79x
EV/EBITDA	12.32x
EV/Sales	7.43x
P/B ratio	1.2x
P/S ratio	3.07x
PE Ratio5 Y	117.53x
PS Forward	3.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	24.14%
EBITDA Margin	60.32%
Gross margin	100%
Gross Profit	$151.5M
Net Income	$-15M
Net Income Growth Q	-51.56%
Net Income Growth Years	0%
Pretax Margin	-5.92%
Profit Margin	-5.06%
Profit Per Employee	$-498,967
ROA	1.82
Roa5y	1.84
ROCE	3.02
ROE	-1.69
Roe5y	1.96
ROIC	1.89

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	102.83%
Cagr1y	-4.02%
Cagr3y	-0.39%
Cagr5y	-6.31%
Div CAGR10	-4.36%
Div CAGR3	-10.61%
Div CAGR5	-5.83%
EPS Growth Years	0
OCF Growth	9.8%
OCF Growth Q	8.8%
OCF Growth3 Y	-0.52%
OCF Growth5 Y	14.75%
Revenue Growth	9.63x
Revenue Growth Q	10.05x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	2.28x
Revenue Growth5 Y	8.79x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.12
Assets	$1.2B
Cash	$15.4M
Debt	$676.7M
Debt EBITDA	$7.03
Debt Equity	$1.3
Equity	$520.7M
Interest Coverage	1.15
Liabilities	$717.4M
Net Cash	$-661.3M
Net Cash By Market Cap	$-142
Net Debt EBITDA	$7.24
Net Debt Equity	$1.27
Tangible Book Value	$339.9M
Tangible Book Value Per Share	$25.68
WACC	6.49

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.99
Net Working Capital	$-14.9M
Quick ratio	0.78
Working Capital	$-407,000

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.7%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	$1.92
Dividend Years	13
Dividend Yield	5.65%
Ex Div Date	2026-05-20
Last Dividend	$0.25
Payout Frequency	Monthly

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	117,626.52%
1Y total return	-4.01%
200-day SMA	34.4
3Y total return	-1.16%
50-day SMA	34.7
50-day SMA vs 200-day SMA	50over200
5Y total return	-27.8%
All Time High	92.55
All Time High Change	-63.27%
All Time High Date	2022-01-04
All Time Low	0.63
All Time Low Change	5,338.4%
All Time Low Date	2016-02-01
ATR	1.29
Beta	1.14
Beta1y	0.93
Beta2y	0.66
Ch YTD	0.74
High	34.39
High52	39.93
High52 Date	2025-09-22
High52ch	-14.88%
Low	32.3
Low52	29.05
Low52 Date	2026-05-07
Low52ch	17.01%
Ma50ch	-2.03%
Price vs 200-day SMA	-1.19%
RSI	45.35
RSI Monthly	42.75
RSI Weekly	47.44
Sharpe ratio	-0.09x
Sortino ratio	0.04
Total Return	4.95%
Tr YTD	2.18
Tr1m	1.35%
Tr1w	-4.17%
Tr3m	-5.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Hold
Earnings EPS Estimate	$0.01
Earnings EPS Estimate Growth	-99.09
Earnings Revenue Estimate	38,088,330x
Earnings Revenue Estimate Growth	10.1x
Operating Income	$36.6M
Operating margin	24.14
Price target	$38
Price Target Change	$11.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12,418,350%
Float Percent	90.79%
Shares Insiders	0.55%
Shares Institutions	66.07%
Shares Out	13,678,830
Shares Qo Q	-1.02%
Shares Yo Y	0.7%
Short Float	4.42%
Short Ratio	5.24
Short Shares	4.01

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	124,718.8x
Bv Per Share	28.42
Ch10y	5,338.4
Ch1m	0.65
Ch1w	-4.17
Ch1y	-11.6
Ch3m	-7.21
Ch3y	-24.13
Ch5y	-51.82
Ch6m	5.07
Change	5.23%
Change From Open	5.23
Close	32.3
Days Gap	0
Depreciation Amortization	44,805,000
Dollar Volume	9,687,897.8
Earnings Date	2026-05-06
Earnings Time	amc
EBIT	$36.6M
EBITDA	$91.4M
EPS	$-1.12
F Score	4
Ffo	56,856,000
Financing CF	-28,296,000
Fiscal Year End	December
Founded	2,011
Goodwill	5,903,000
Investing CF	-43,022,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2025-09-22
Last Split Type	Reverse
Ma150	34.05
Ma150ch	-0.19%
Ma20	35.22
Ma20ch	-3.49%
Net CF	3,372,000
Next Earnings Date	2026-08-05
Open	32.3
Optionable	Yes
P OCF Ratio	6.22
Payment Date	2026-06-12
Position In Range	80.86
Post Close	33.99
Postmarket Change Percent	0.61
Postmarket Price	$34.2
Ppne	1,113,189,000
Price Date	2026-05-08
Price EBITDA	$5.09
Ptbv Ratio	1.37
Relative Volume	2.29x
Revenue	151,533,000x
SBC By Revenue	3.68x
Share Based Comp	5,574,000
Tr6m	8.9%
Us State	Maryland
Volume	285,022

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

XRN dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.6%

$1.92 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-5.8%

0 consecutive years of growth

Total shareholder yield

+5.0%

Next ex-dividend date: 2026-05-20

Performance

XRN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns XRN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+66.1%

Float: +90.8% of shares outstanding

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

XRN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.4

Neutral momentum band

Price vs 200-day MA

-1.2%

50/200-day relationship not available

Beta (5Y)

1.14

Moves roughly with the market

Sharpe ratio

-0.09

Risk-adjusted return — higher is better; >1.0 is solid.

Peers

XRN vs. sector cohort

Currency-neutral comparison: P/E, P/S, ROIC, 5Y revenue CAGR, and 1Y total return. Market-cap column appears only when every peer reports in the same currency.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
PLD	Prologis Inc.	137.2B	36.3x	14.6x	3.9%	+13.9%	+41.9%	Sell
WELL	Welltower Inc.	151.5B	104.9x	12.9x	1.1%	+21.8%	+44.2%	Sell

Questions

About XRN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current XRN stock rating?

Chiron Real Estate Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full XRN analysis?

The full report lives at /stocks/XRN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for XRN?

The latest report frames XRN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the XRN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.